|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/13/20 Cell Source, Inc. 10-Q 9/30/20 50:3.2M Pubco Reporting … Inc/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 398K
2: EX-10.54 Material Contract HTML 51K
3: EX-10.55 Material Contract HTML 53K
4: EX-10.56 Material Contract HTML 37K
5: EX-10.57 Material Contract HTML 36K
6: EX-10.58 Material Contract HTML 35K
7: EX-10.59 Material Contract HTML 51K
8: EX-31 Certification -- §302 - SOA'02 HTML 19K
9: EX-32 Certification -- §906 - SOA'02 HTML 15K
16: R1 Cover HTML 47K
17: R2 Condensed Consolidated Balance Sheets HTML 85K
18: R3 Condensed Consolidated Balance Sheets HTML 43K
(Parenthetical)
19: R4 Condensed Consolidated Statements of Operations HTML 63K
(Unaudited)
20: R5 Condensed Consolidated Statements of Changes in HTML 92K
Stockholders' Deficit (Unaudited)
21: R6 Condensed Consolidated Statements of Cash Flows HTML 118K
(Unaudited)
22: R7 Business Organization Nature of Operations and HTML 24K
Basis of Presentation
23: R8 Going Concern and Management Plans HTML 20K
24: R9 Summary of Significant Accounting Policies HTML 25K
25: R10 Fair Value HTML 78K
26: R11 Advances Payable HTML 18K
27: R12 Notes Payable and Convertible Notes Payable HTML 27K
28: R13 Stockholders' Deficiency HTML 27K
29: R14 Related Party Transactions HTML 19K
30: R15 Commitments and Contingencies HTML 21K
31: R16 Subsequent Events HTML 21K
32: R17 Summary of Significant Accounting Policies HTML 28K
(Policies)
33: R18 Summary of Significant Accounting Policies HTML 22K
(Tables)
34: R19 Fair Value (Tables) HTML 69K
35: R20 Going Concern and Management Plans (Detail HTML 28K
Narrative)
36: R21 Summary of Significant Accounting Policies HTML 23K
(Details)
37: R22 Summary of Significant Accounting Policies (Detail HTML 19K
Narrative)
38: R23 Fair Value (Details) HTML 39K
39: R24 Fair Value (Details 1) HTML 28K
40: R25 Fair value (Details 2) HTML 57K
41: R26 Fair Value (Details Narrative) HTML 21K
42: R27 Advance Payable (Details Narrative) HTML 25K
43: R28 Notes Payable and Convertible Notes Payable HTML 114K
(Details Narrative)
44: R29 Stockholders Deficiency (Details Narrative) HTML 109K
45: R30 Related Party Transactions (Details Narrative) HTML 24K
46: R31 Commitments and Contingencies (Details Narrative) HTML 22K
47: R32 Subsequent Events (Details Narrative) HTML 43K
49: XML IDEA XML File -- Filing Summary XML 76K
48: EXCEL IDEA Workbook of Financial Reports XLSX 54K
10: EX-101.INS XBRL Instance -- clcs-20200930 XML 876K
13: EX-101.CAL XBRL Calculations -- clcs-20200930_cal XML 102K
15: EX-101.DEF XBRL Definitions -- clcs-20200930_def XML 404K
12: EX-101.LAB XBRL Labels -- clcs-20200930_lab XML 652K
14: EX-101.PRE XBRL Presentations -- clcs-20200930_pre XML 534K
11: EX-101.SCH XBRL Schema -- clcs-20200930 XSD 135K
50: ZIP XBRL Zipped Folder -- 0001640334-20-002809-xbrl Zip 84K
EXHIBIT 31
CERTIFICATION OF
CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
I, Itamar Shimrat, certify that:
| 1. | I have reviewed this Quarterly Report on Form 10-Q of Cell Source, Inc.; |
|
|
|
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
|
|
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
|
|
| 4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
| a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
|
|
|
| b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
|
|
|
| c) | evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
|
|
|
| d) | disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
| 5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|
| a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
|
|
|
|
| b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: November 13, 2020
| /s/ Itamar Shimrat |
|
|
| |
| Chief Executive Officer and Chief Financial Officer |
|
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/13/20 | None on these Dates | ||
| For Period end: | 9/30/20 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/08/23 Cell Source, Inc. 10-K 12/31/22 77:11M M2 Compliance LLC/FA 4/15/22 Cell Source, Inc. 10-K 12/31/21 75:11M M2 Compliance LLC/FA 4/15/21 Cell Source, Inc. 10-K 12/31/20 71:6.4M Pubco Reporting … Inc/FA |